A 58-year-old man with a 20-pack-year smoking history presents with intermittent claudication of the left lower limb. On examination, he has absent femoral pulses bilaterally and an ankle-brachial index of 0.45 on the left. He is already on aspirin and a statin. What is the drug of choice to reduce claudication symptoms and improve walking distance?

Explanation

## Pharmacological Management of Intermittent Claudication **Key Point:** Cilostazol is the most effective antiplatelet and vasodilatory agent for symptomatic relief of intermittent claudication, with proven efficacy in increasing walking distance. ### Mechanism of Cilostazol 1. **Phosphodiesterase-3 inhibitor** — increases cAMP in platelets and vascular smooth muscle 2. **Dual action:** - Antiplatelet effect (reduces thrombotic events) - Vasodilation (improves blood flow) 3. **Additional benefit:** improves hemorheology (blood viscosity) ### Comparative Efficacy Table | Drug | Mechanism | Evidence for Claudication | Adverse Effects | |------|-----------|---------------------------|------------------| | **Cilostazol** | PDE-3 inhibitor | Strong (increases walking distance 40–60%) | Tachycardia, palpitations, headache | | Pentoxifylline | Rheologic agent | Modest (marginal benefit) | GI upset, dizziness | | Naftidrofuryl | Vasodilator | Weak evidence | Nausea, GI disturbance | | Ticlopidine | Antiplatelet | No specific claudication benefit | Neutropenia, TTP risk | **High-Yield:** Cilostazol improves maximal walking distance and pain-free walking distance in claudication — the only agent with robust RCT evidence in this indication. ### Clinical Pearl Cilostazol is contraindicated in heart failure (inotropic effect worsens outcomes) and should be avoided in patients with recent MI or unstable angina. Pentoxifylline has largely fallen out of favor due to weak evidence and poor tolerability. **Warning:** Do not confuse cilostazol's antiplatelet action with aspirin — cilostazol is added *to* aspirin in PAD, not as a replacement. ### Treatment Algorithm for Intermittent Claudication ```mermaid flowchart TD A[Intermittent Claudication Diagnosed]:::outcome --> B[Smoking cessation + Exercise program]:::action B --> C[Aspirin + Statin]:::action C --> D{Symptoms persist?}:::decision D -->|Yes| E[Add Cilostazol 100 mg BD]:::action D -->|No| F[Continue medical management]:::action E --> G{Tachycardia/palpitations?}:::decision G -->|Yes| H[Reduce dose or switch to pentoxifylline]:::action G -->|No| I[Continue; reassess at 12 weeks]:::action I --> J{Improvement in walking distance?}:::decision J -->|Yes| K[Maintain therapy]:::outcome J -->|No| L[Consider revascularization]:::action ``` [cite:Harrison 21e Ch 244]